Shareholder reduces voting rights in ChemoMetec A/S
1 report, 1 independent
Updated Oct 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A shareholder notified ChemoMetec A/S that on October 15, 2026, it reduced its voting rights attached to shares to 14.97%, which is below the 15% threshold set by the Danish Capital Markets Act. Concurrently, the shareholder increased its position in voting rights attached to financial instruments to 0.11%. The total aggregate voting rights position remains 15.08%.
From manilatimes.net
Why it matters
The reduction in voting rights triggers specific regulatory requirements under the Danish Capital Markets Act regarding major shareholdings. ChemoMetec develops and markets instruments used by the pharmaceutical, biotech, and agricultural industries worldwide.
From manilatimes.net
Who's involved
- ChemoMetecA company that develops and markets instruments for cell counting to the pharmaceutical, biotech, and agricultural industries
Keep exploring
The entities involved
-
ChemoMetec
Nothing else this week.